Germany· DE-A57-e564afe2898f67df
Moviprep
A medicinal product containing ascorbic acid, sodium ascorbate, potassium chloride, sodium chloride, sodium sulfate, anhydrous, macrogol 3350, registered in Germany by Norgine B.V..
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate, Anhydrous, Macrogol 3350
- Manufacturer
- Norgine B.V.
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd590a50-c9a3-493a-952d-3d474411cad8 GET /v1/drugs/cd590a50-c9a3-493a-952d-3d474411cad8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate, Anhydrous, Macrogol 3350",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about ascorbic acid, sodium ascorbate, potassium chloride, sodium chloride, sodium sulfate, anhydrous, macrogol 3350.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.